Eli Lilly

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Eli Lilly and other ETFs, options, and stocks.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture and sale of pharmaceutical products. The firm's products consist of Diabetes, Oncology, Immunology, Neuroscience, and Other therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
35,000
Employees35,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
35,000
Employees35,000

LLY Key Statistics

Market cap
343.54B
Market cap343.54B
Price-Earnings ratio
52.53
Price-Earnings ratio52.53
Dividend yield
1.12
Dividend yield1.12
Average volume
2.73M
Average volume2.73M
High today
$352.18
High today$352.18
Low today
$346.75
Low today$346.75
Open price
$350.86
Open price$350.86
Volume
2.57M
Volume2.57M
52 Week high
$384.44
52 Week high$384.44
52 Week low
$231.87
52 Week low$231.87

LLY News

CNBC 7h
Jim Cramer's Investing Club meeting Thursday: Stocks rise, Eli Lilly, Meta

Every weekday the CNBC Investing Club with Jim Cramer holds a "Morning Meeting" livestream at 10:20 a.m. ET. Here's a recap of Thursday's key moments. Continue...

Jim Cramer's Investing Club meeting Thursday: Stocks rise, Eli Lilly, Meta
Yahoo Finance 9h
Lilly Supports Direct Relief’s Efforts To Expand Access to Medicines by Improving Cold Chain Capacity - Yahoo Finance

INDIANAPOLIS, IN and SANTA BARBARA, CA / ACCESSWIRE / January 26, 2023 / Direct Relief: Eli Lilly and Company (NYSE:LLY) and Direct Relief today announced a ne...

Lilly Supports Direct Relief’s Efforts To Expand Access to Medicines by Improving Cold Chain Capacity - Yahoo Finance
Benzinga 1d
Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today - Benzinga

Eli Lilly LLY has outperformed the market over the past 15 years by 6.23% on an annualized basis producing an average annual return of 13.61%. Currently, Eli Li...

Here's How Much $1000 Invested In Eli Lilly 15 Years Ago Would Be Worth Today - Benzinga

Analyst ratings

71%

of 24 ratings
Buy
70.8%
Hold
29.2%
Sell
0%

LLY Earnings

$0.00
$0.87
$1.75
$2.62
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
$1.92 per share
Estimated$1.92 per share
Actual
Available Feb 2, Pre-Market
ActualAvailable Feb 2, Pre-Market

More LLY News

Barron's 2d
Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs

Text size Two of last year’s strongest drug stocks were energized by weight loss. While the overall equity market sagged in 2022, Eli Lilly (ticker: LLY) rose...

Eli Lilly, Novo Nordisk Get a Share-Price Pop From Weight-Loss Drugs
Yahoo Finance 2d
Eli Lilly Gains As Market Dips: What You Should Know - Yahoo Finance

In the latest trading session, Eli Lilly (LLY) closed at $346.39, marking a +1.22% move from the previous day. The stock outpaced the S&P 500's daily loss of 0....

Eli Lilly Gains As Market Dips: What You Should Know - Yahoo Finance
Reuters 2d
Eli Lilly to invest $450 mln more to expand capacity as obesity drug ... - Reuters

Jan 24 (Reuters) - Eli Lilly and Co plans to invest an additional $450 million to expand capacity of a plant in North Carolina, the U.S. drugmaker...

Eli Lilly to invest $450 mln more to expand capacity as obesity drug ... - Reuters
Benzinga 2d
Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023 - Benzinga

The United States Food and Drug Administration (FDA) approved 45 new drugs in 2022.1 Though the number of approvals was the lowest since 2016, nearly half of th...

Another Year of Blockbuster Drug and Treatment Approvals Possible in 2023 - Benzinga
Bloomberg 2d
Eli Lilly Plans Manufacturing Expansion as Obesity Drug Demand ... - Bloomberg

Eli Lilly & Co. will spend $450 million to expand a manufacturing site in North Carolina as demand grows for its diabetes drug that also has the potential to tr...

Eli Lilly Plans Manufacturing Expansion as Obesity Drug Demand ... - Bloomberg
Reuters 3d
Eli Lilly to invest $450 mln to expand diabetes drug plant capacity

Jan 24 (Reuters) - Eli Lilly and Co said on Tuesday it plans to invest an additional $450 million to expand its manufacturing capacity at the Research Triangle...

Eli Lilly to invest $450 mln to expand diabetes drug plant capacity
MarketWatch 3d
Eli Lilly to invest additional $450 million in Research Triangle Park facility, to add at least 100 jobs

Eli Lilly & Co. LLY, -1.12% said Tuesday it’s planning to invest an additional $450 million in a manufacturing site at Research Triangle Park in North Carolina...

Eli Lilly to invest additional $450 million in Research Triangle Park facility, to add at least 100 jobs
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.